Strategies for Monitoring and Supplementation Given the consistent evidence, anyone on a GLP-1 medication should treat vitamin D monitoring as a non-negotiable part of their treatment protocol[4]Vitamin D Fact Sheet NIH ODS View source: Baseline and follow-up serum testing check 25(OH)D levels before starting GLP-1 therapy and every 6 months thereafter.[10]Vitamin D Deficiency N Engl J Med View source Target range: 4060 ng/mL Vitamin D3 supplementation 2,0004,000 IU/day of vitamin D3 (see full dosage guide), adjusted based on blood test results.[14]Vitamin D Receptor in Nerve Cells Journal of Steroid Biochemistry View source Take with the fattiest meal of the day for optimal absorption[5]Vitamin D Absorption with Fat NCBI View source Pair with calcium and magnesium vitamin D works synergistically with both
Studies in animals show GLP-1 receptor agonists can reduce alcohol intake by over 50% in rats 23
5,21,22 Although causality is often difficult to establish, clinical case reports and postmarketing pharmacovigilance studies suggest a classwide signal that warrants continued monitoring
Tirzepatide formulations often include glycine and B12 or niacinamide as supporting compounds
Specifically, they proposed an approach in which GLP-1RAs could be prescribed for an initial period of weight loss before patients transitioned to cheaper alternative interventions for weight maintenance such as lower-cost medications, behavioral health programs and support from nutritionists
JAMA Netw Open
